Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
BACKGROUND: A number of important scientific advances can be made through the study of
blood, bone marrow, tumor, or other tissue samples from patients with HIV infection,
infection with Kaposi's sarcoma associated herpesvirus (KSHV), infection with other
oncogenic viruses, or cancer. This protocol provides a mechanism to effect a variety of such
OBJECTIVES: Acquisition of serum, circulating cells, bone marrow, and tumor or normal tissue
samples from patients with HIV infection, KSHV infection, or with cancer.
ELIGIBILITY: Eligibility criteria include age 18 years or older and at least one of the
following: Exposure risk to HIV, KSHV, or HPV; HIV seropositive; KSHV seropositive; EBV
seropositive; HTLV-1 seropositive; malignancy, Castleman's disease, or skin lesions with
appearance of Kaposi's sarcoma; or cervical or anal intraepithelial lesion.
DESIGN: Blood samples may be collected at the initial visit, and at follow-up visits. Tumor
samples may be obtained by fine needle aspirate, by removal of pleural or peritoneal fluid,
by skin punch biopsy, or by excisional biopsy, providing the tumor is accessible with
minimal risk to the patients. Specific risks will be described in a separate consent to be
obtained at the time of the biopsy. Samples will be studied in the HIV and AIDS Malignancy
Branch, CCR, NCI; laboratories in NCI-Frederick; or those of collaborating investigators.
Robert Yarchoan, M.D.
National Cancer Institute (NCI)
United States: Federal Government
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Bethesda, Maryland 20892|